National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
inalimarev (IN-uh-LIM-uh-rev)

 A cancer vaccine made with a form of vaccinia virus that does not cause disease in humans. It is being studied in the treatment of some types of cancer. The virus is changed in the laboratory to make human proteins, including the tumor markers called CEA and MUC-1, that may help immune cells in the body kill tumor cells. Also called recombinant vaccinia-CEA-MUC-1-TRICOM vaccine and PANVAC-V.

Previous Definitions:In 111 ibritumomab tiuxetan, In 111 Zevalin, in vitro, in vitro fertilization, in vivo
Next Definitions:incidence, incision, incisional biopsy, incomplete Freund's adjuvant, incontinence